These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2856727)

  • 1. Effects of human atrial natriuretic peptide on the pressor action of noradrenaline and angiotensin II in normal subjects.
    Uehlinger DE; Weidmann P; Gnädinger MP; Shaw S
    J Hypertens Suppl; 1985 Dec; 3(3):S319-21. PubMed ID: 2856727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man.
    Uehlinger DE; Weidmann P; Gnaedinger MP; Shaw S; Lang RE
    J Clin Endocrinol Metab; 1986 Sep; 63(3):669-74. PubMed ID: 2942555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood levels and renal effects of atrial natriuretic peptide in normal man.
    Weidmann P; Hasler L; Gnädinger MP; Lang RE; Uehlinger DE; Shaw S; Rascher W; Reubi FC
    J Clin Invest; 1986 Mar; 77(3):734-42. PubMed ID: 2936762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of human atrial natriuretic peptide on angiotensin II-induced secretion of aldosterone in man.
    Vierhapper H
    Klin Wochenschr; 1986; 64 Suppl 6():50-2. PubMed ID: 2948063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium and responses to infused noradrenaline and angiotensin II in subjects predisposed to hypertension.
    Pusterla C; Beretta-Piccoli C; Städler P; Weidmann P; Shaw S
    J Hum Hypertens; 1988 Mar; 1(4):267-76. PubMed ID: 3065505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension.
    Weidmann P; Gnädinger MP; Ziswiler HR; Shaw S; Bachmann C; Rascher W; Uehlinger DE; Hasler L; Reubi FC
    J Hypertens Suppl; 1986 Jun; 4(2):S71-83. PubMed ID: 2941546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of norepinephrine and angiotensin II on plasma atrial natriuretic peptide concentration in humans.
    Shimamoto K; Nakagawa M; Fukuyama S; Ura N; Murakami H; Yonekura S; Iwakura M; Yamaguchi Y; Ise T; Saitoh S
    J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S59-62. PubMed ID: 2473353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin I- and II- and norepinephrine-mediated pressor responses in an ancient holostean fish, the bowfin (Amia calva).
    Butler DG; Oudit GY; Cadinouche MZ
    Gen Comp Endocrinol; 1995 Jun; 98(3):289-302. PubMed ID: 7628688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II.
    Cargill RI; Struthers AD; Lipworth BJ
    Cardiovasc Res; 1995 Jan; 29(1):108-11. PubMed ID: 7895227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function.
    Schafferhans K; Heidbreder E; Hummel S; Heidland A
    Z Kardiol; 1988; 77 Suppl 2():78-84. PubMed ID: 2970179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat.
    Zukowska-Grojec Z; Haass M; Kopin IJ; Zamir N
    J Pharmacol Exp Ther; 1986 Nov; 239(2):480-7. PubMed ID: 2877083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute mild hypercalcemia or of the calcium antagonist nifedipine on cardiovascular responsiveness to norepinephrine or angiotensin II in normal humans.
    Beretta-Piccoli C; Bianchetti MG; Weidmann P; Boehringer K; Link L; Morton JJ
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S306-12. PubMed ID: 6184559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal interstitial hydrostatic pressure and natriuretic response to high doses of angiotensin II in pregnant rats.
    Yu T; Khraibi AA
    Am J Hypertens; 2006 Mar; 19(3):300-5. PubMed ID: 16500518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic response to atrial natriuretic factor enhanced by angiotensin II and vasopressin.
    Trippodo NC; MacPhee AA; Cole FE
    J Hypertens Suppl; 1984 Dec; 2(3):S289-91. PubMed ID: 6242556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepant effects of angiotensin II and phenylephrine on plasma volume in conscious goats.
    Olsson K; Hossaini-Hilali J; Cvek K
    Acta Physiol Scand; 1994 May; 151(1):83-90. PubMed ID: 8048338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
    Klemm SA; Tunny TJ; Gordon RD
    J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma levels of atrial natriuretic peptide in patients with chronic renal failure: effect of noradrenaline infusion.
    Jespersen B; Pedersen EB
    Nephrol Dial Transplant; 1988; 3(6):762-7. PubMed ID: 2976128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diuretic, natriuretic and hypotensive effects of synthetic atrial natriuretic factor in conscious newborn calves.
    Amadieu M; Giry J; Barlet JP
    J Dev Physiol; 1988 Feb; 10(1):37-45. PubMed ID: 2965177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of plasma concentrations of human atrial natriuretic peptide to renal function and blood pressure in patients with progressive chronic renal failure.
    Predel HG; Bäcker A; Kipnowski J; Düsing R; Kramer HJ
    Klin Wochenschr; 1987; 65 Suppl 8():127-32. PubMed ID: 2955161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.